Axonics
AXNX · NASDAQ
$0.429−$0.0611 (−12.47%)TodayMarket closed ·
Prev close $0.4901
About AXNX
- Employees
- 797
- Headquarters
- Irvine, California
- Listed
- Oct 31, 2018
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Website
- axonics.com
Leadership
| Name | Title | Since |
|---|---|---|
| Jonathan Monson | — | 2024 |
| Daniel Brennan | — | — |
| Michael Mahoney | — | — |
| Karen Noblett | — | — |
| Vance Brown | — | — |
Revenue by product and region
Fiscal year ended Dec 31, 2022: $273.70M total revenue
By product
- SNM net revenue$221.99M81.1%
- Bulkamid net revenue$51.71M18.9%
Suppliers and customers
Price correlation is over one year: 1 means the stocks move together, -1 opposite
| Company | Relationship | Correlation |
|---|---|---|
| Alfred E. Mann Foundation For Scientific Research | Supplier and customer | — |
| Micro Systems Technologies Management AG | Supplier and customer | — |
Similar companies
Companies in the same industry as Axonics
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.